Benjamin J. Hindson - Dec 28, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Scientific Officer and President, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Dec 28, 2021
Transactions value $
$129,690
Form type
4
Date filed
12/30/2021, 06:31 PM
Previous filing
Dec 3, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $57.7K +54K +115.37% $1.07* 101K Dec 28, 2021 Direct
transaction TXG Class A Common Stock Options Exercise $72K +60K +59.54% $1.20* 161K Dec 28, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -54K -100% $0.00* 0 Dec 28, 2021 Class A Common Stock 54K $1.07 Direct F1
transaction TXG Stock Option (right to buy) Options Exercise $0 -60K -100% $0.00* 0 Dec 28, 2021 Class A Common Stock 60K $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Remarks:

Chief Scientific Officer and President